Length of Hospital Stay and Complications After Percutaneous Transluminal Coronary Angioplasty
Mark W. Wolfe(Brigham and Women's Hospital), John A. Bittl(Brigham and Women's Hospital), Henry S. Cabin(Brigham and Women's Hospital), John Strony(Merck & Co., Inc., Rahway, NJ, USA (United States)), Adam Cannon(Brigham and Women's Hospital), Ferdinand Leya(Brigham and Women's Hospital), James J. Ferguson(Brigham and Women's Hospital), Jeffrey M. Isner(Tufts University), Gary S. Roubin(Lenox Hill Hospital), Burt Adelman(Massachusetts General Hospital), Michael Cleman(Brigham and Women's Hospital), Raoul Bonan(Montreal Heart Institute), Marc J. Schweiger(Brigham and Women's Hospital)
Cited by 53
Related Papers
Stenting versus Endarterectomy for Treatment of Carotid-Artery Stenosis
|New England Journal of Medicine|2010|3k
Nitric oxide synthase modulates angiogenesis in response to tissue ischemia.
|Journal of Clinical Investigation|1998|1.2k
Gene Therapy for Myocardial Angiogenesis
|Circulation|1998|993
Percutaneous Aortic Valve Replacement for Severe Aortic Stenosis in High-Risk Patients Using the Second- and Current Third-Generation Self-Expanding CoreValve Prosthesis
|Journal of the American College of Cardiology|2007|947
Vorapaxar in the Secondary Prevention of Atherothrombotic Events
|New England Journal of Medicine|2012|941